Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
4.610
+0.060 (1.32%)
At close: Oct 13, 2025, 4:00 PM EDT
4.850
+0.240 (5.21%)
After-hours: Oct 13, 2025, 5:58 PM EDT
Inventiva Market Cap
Inventiva has a market cap or net worth of $608.58 million as of October 13, 2025. Its market cap has increased by 544.36% in one year.
Market Cap
608.58M
Enterprise Value
620.48M
1-Year Change
544.36%
Ranking
Category
Stock Price
$4.61
Market Cap Chart
Since October 26, 2018, Inventiva's market cap has increased from $151.00M to $608.58M, an increase of 303.03%. That is a compound annual growth rate of 22.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 608.58M | 181.87% |
| Dec 31, 2024 | 215.91M | -7.64% |
| Dec 29, 2023 | 233.77M | 16.05% |
| Dec 30, 2022 | 201.44M | -63.07% |
| Dec 31, 2021 | 545.53M | -0.85% |
| Dec 31, 2020 | 550.21M | 397.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |